1. Association between breast cancer risk and disease aggressiveness: Characterizing underlying gene expression patterns. Issue 4 (5th September 2020) Authors: Ugalde‐Morales, Emilio; Grassmann, Felix; Humphreys, Keith; Li, Jingmei; Eriksson, Mikael; Tobin, Nicholas P.; Borg, Åke; Vallon‐Christersson, Johan; Hall, Per; Czene, Kamila Journal: International journal of cancer Issue: Volume 148:Issue 4(2021) Page Start: 884 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Astrocytes enhance glioblastoma growth. Issue 2 (11th September 2019) Authors: Mega, Alessandro; Hartmark Nilsen, Mette; Leiss, Lina Wik; Tobin, Nicholas P.; Miletic, Hrvoje; Sleire, Linda; Strell, Carina; Nelander, Sven; Krona, Cecilia; Hägerstrand, Daniel; Enger, Per Ø.; Nistér, Monica; Östman, Arne Journal: Glia Issue: Volume 68:Issue 2(2020) Page Start: 316 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Breast cancer in young women and prognosis: How important are proliferation markers?. (October 2017) Authors: Fredholm, Hanna; Magnusson, Kristina; Lindström, Linda S.; Tobin, Nicholas P.; Lindman, Henrik; Bergh, Jonas; Holmberg, Lars; Pontén, Fredrik; Frisell, Jan; Fredriksson, Irma Journal: European journal of cancer Issue: Volume 84(2017) Page Start: 278 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical and molecular characteristics of estrogen receptor‐positive ultralow risk breast cancer tumors identified by the 70‐gene signature. Issue 12 (7th March 2022) Authors: Johansson, Annelie; Yu, Nancy Y.; Iftimi, Adina; Tobin, Nicholas P.; van 't Veer, Laura; Nordenskjöld, Bo; Benz, Christopher C.; Fornander, Tommy; Perez‐Tenorio, Gizeh; Stål, Olle; Esserman, Laura J.; Yau, Christina; Lindström, Linda S. Journal: International journal of cancer Issue: Volume 150:Issue 12(2022) Page Start: 2072 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Erratum to "Multi‐level gene expression signatures, but not binary, outperform Ki67 for the long term prognostication of breast cancer patients" [MOLONC 8 (2014) 741–752]. Issue 6 (11th July 2014) Authors: Tobin, Nicholas P.; Lindström, Linda S.; Carlson, Joseph W.; Bjöhle, Judith; Bergh, Jonas; Wennmalm, Kristian Other Names: Peeper Daniel specialEditor. Journal: Molecular oncology Issue: Volume 8:Issue 6(2014:Sep.) Page Start: 1159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Interval breast cancer is associated with interferon immune response. (February 2022) Authors: Ugalde-Morales, Emilio; Grassmann, Felix; Humphreys, Keith; Li, Jingmei; Eriksson, Mikael; Tobin, Nicholas P.; Lindström, Linda S.; Vallon-Christersson, Johan; Borg, Åke; Hall, Per; Czene, Kamila Journal: European journal of cancer Issue: Volume 162(2022) Page Start: 194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Intrinsic subtypes and genomic signatures of primary breast cancer and prognosis after systemic relapse. Issue 4 (18th November 2015) Authors: Falato, Claudette; Tobin, Nicholas P.; Lorent, Julie; Lindström, Linda S.; Bergh, Jonas; Foukakis, Theodoros Journal: Molecular oncology Issue: Volume 10:Issue 4(2016:Apr.) Page Start: 517 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Multi‐level gene expression signatures, but not binary, outperform Ki67 for the long term prognostication of breast cancer patients. Issue 3 (28th February 2014) Authors: Tobin, Nicholas P.; Lindström, Linda S.; Carlson, Joseph W.; Bjöhle, Judith; Bergh, Jonas; Wennmalm, Kristian Journal: Molecular oncology Issue: Volume 8:Issue 3(2014:May) Page Start: 741 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Programmed death‐ligand 1 gene expression is a prognostic marker in early breast cancer and provides additional prognostic value to 21‐gene and 70‐gene signatures in estrogen receptor‐positive disease. Issue 5 (20th March 2020) Authors: Zerdes, Ioannis; Sifakis, Emmanouil G.; Matikas, Alexios; Chrétien, Sebastian; Tobin, Nicholas P.; Hartman, Johan; Rassidakis, George Z.; Bergh, Jonas; Foukakis, Theodoros Journal: Molecular oncology Issue: Volume 14:Issue 5(2020) Page Start: 951 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial. Issue 35 (10th December 2022) Authors: Johansson, Annelie; Dar, Huma; van 't Veer, Laura J.; Tobin, Nicholas P.; Perez-Tenorio, Gizeh; Nordenskjöld, Anna; Johansson, Ulla; Hartman, Johan; Skoog, Lambert; Yau, Christina; Benz, Christopher C.; Esserman, Laura J.; Stål, Olle; Nordenskjöld, Bo; Fornander, Tommy; Lindström, Linda S. Journal: Journal of clinical oncology Issue: Volume 40:Issue 35(2022) Page Start: 4071 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗